Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

330
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
330
Angina V: Nursing Management01:20

Angina V: Nursing Management

370
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
370
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

285
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
285
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

388
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
388
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

320
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
320
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

315
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patients.

Coronary artery disease·2026
Same author

Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

(Long-term) efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders.

International journal of cardiology·2026
Same author

ESC-JCS Joint Symposium at the 89th Japanese Circulation Society Annual Meeting: focus on angina with non-obstructive coronary arteries.

European heart journal·2026
Same author

The future of coronary function testing - angio-derived assessments are on the advance.

International journal of cardiology·2025
Same author

Long-Term Risk in Patients With ANOCA: It May Not Kill, But It Does Still Hurt.

JACC. Cardiovascular interventions·2025

Related Experiment Video

Updated: Feb 20, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.0K

[Optimal Diagnostics and Therapy for Microvascular Angina Pectoris].

Peter Ong, Udo Sechtem

    Deutsche Medizinische Wochenschrift (1946)
    |October 19, 2017
    PubMed
    Summary

    Microvascular angina involves chest pain due to reduced blood flow in heart vessels, affecting 10-50% of patients. Treatment focuses on risk factors and tailored antianginal medications.

    Area of Science:

    • Cardiology
    • Vascular Medicine

    Background:

    • Microvascular angina presents as angina pectoris with myocardial ischemia, but without significant epicardial coronary artery stenosis or heart muscle disease.
    • This condition, classified as type 1 coronary microvascular dysfunction, stems from structural and functional changes in coronary microvessels (<500 µm diameter).
    • These microvascular alterations are often linked to common cardiovascular risk factors and affect a substantial percentage of patients undergoing coronary angiography.

    Purpose of the Study:

    • To summarize the characteristics, diagnostic approaches, and treatment strategies for patients suffering from microvascular angina.
    • To highlight the challenges in managing this condition and emphasize the importance of personalized treatment.

    Main Methods:

    • Non-invasive diagnostics: coronary CT-angiography, positron emission tomography, and echo Doppler-based coronary flow reserve measurements.

    More Related Videos

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
    05:58

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

    Published on: February 3, 2021

    4.3K
    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    3.8K

    Related Experiment Videos

    Last Updated: Feb 20, 2026

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
    10:28

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

    Published on: March 15, 2022

    6.0K
    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
    05:58

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

    Published on: February 3, 2021

    4.3K
    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    3.8K
  • Invasive diagnostics: coronary flow reserve measurements (adenosine-stimulated) and intracoronary acetylcholine testing.
  • Treatment strategies involve strict cardiovascular risk factor control and individualized antianginal pharmacotherapy.

    • Main Results:

    • Coronary microvascular dysfunction is the underlying cause of angina in patients without obstructive coronary artery disease.
    • A combination of non-invasive and invasive methods can effectively diagnose microvascular dysfunction.
    • Effective management requires a multi-faceted approach, including risk factor modification and tailored antianginal drug combinations.

    Conclusions:

    • Microvascular angina is a significant clinical entity requiring accurate diagnosis and management.
    • Personalized treatment strategies, based on underlying mechanisms and risk factor control, are crucial for improving patient outcomes.
    • Further research into the mechanisms and optimal therapies for coronary microvascular dysfunction is warranted.